78 | 0 | 7 |
下载次数 | 被引频次 | 阅读次数 |
目的 建立牛黄解毒制剂中9个指标成分的高效液相色谱(HPLC)含量测定方法。方法 采用Xbridge C18色谱柱(4.6 mm × 250 mm,5 μm);流动相为乙腈-0.1%磷酸水溶液,梯度洗脱;流速为1.30 mL/min;柱温为30 ℃;254和280 nm双波长检测。应用所建立的HPLC方法对市售四种牛黄解毒制剂(丸、片、胶囊和软胶囊)11个厂家样品中9个成分进行含量测定。结果 经方法学验证各项指标均合要求。11个厂家牛黄解毒制剂中9个指标成分含量范围为:黄芩苷6.78 ~ 22.03 mg/g、汉黄芩苷1.52 ~ 5.94 mg/g、黄芩素0.33 ~ 2.72 mg/g、甘草酸0.41 ~ 2.85 mg/g、芦荟大黄素0.06 ~ 0.84 mg/g、大黄酸0.10 ~ 1.07 mg/g、大黄素0.08 ~ 1.24 mg/g、大黄酚0.80 ~ 6.55 mg/g、大黄素甲醚0.10 ~ 0.85 mg/g。结论 所建立的HPLC含量测定方法技术简单、灵敏度高、重复性好,可用于牛黄解毒制剂的质量评价。
Abstract:Objective To establish a high performance liquid chromatography (HPLC) method for the content determination of 9 indicator components in Niuhuang Jiedu preparations.Methods A Xbridge C18 column (4.6 mm × 250 mm,5 μm) was used;the mobile phase was acetonitrile-0.1% phosphoric acid aqueous solution with gradient elution;the flow rate was 1.30 mL/min;the column temperature was 30 °C;dual-wavelength detection at 254 and 280 nm.The established HPLC method was applied to determine the content of 9 components in commercial Niuhuang Jiedu preparations (pills,tablets,capsules and soft capsules) from 11 manufacturers.Results The validation of the HPLC methodology met all the required indicators.The content range of 9 indicator components in Niuhuang Jiedu preparations from 11 manufacturers was:baicalin 6.78-22.03 mg/g,wogonoside 1.52-5.94 mg/g,baicalein 0.33-2.72 mg/g,glycyrrhizic acid 0.41-2.85 mg/g,aloeemodin 0.06-0.84 mg/g,rhein 0.10-1.07 mg/g,emodin 0.08-1.24 mg/g,chrysophanic acid 0.80-6.55 mg/g and physcion 0.10-0.85 mg/g.Conclusion The established HPLC method for content determination is technically simple,highly sensitive,and has good repeatability,which can be used for the quality evaluation of Niuhuang Jiedu preparations.
[1]郭允,陈永超,李晓花,等.牛黄解毒片中6种指标成分的含量测定[J].沈阳药科大学学报,2016,33(6):454-458.
[2]张宇静,夏晶,季申,等.牛黄中胆汁酸的药理作用及定量分析方法研究进展[J].国际药学研究杂志,2016,43(2):268-274.
[3]YU Z J,XU Y,PENG W,et al.Calculus bovis:A review of the traditional usages,origin,chemistry,pharmacological activities and toxicology[J].J Ethnopharmacol,2020,254:112649.
[4]林楚慧,柴瑞平,张璐,等.高效液相色谱-电雾式检测器测定牛黄解毒片中的6种胆汁酸[J].分析化学,2022,50(5):764-771.
[5]林诗铃,林逸凡,陈涛,等.基于UPLC-MS对牛黄解毒片中胆酸类成分定量测定及化学模式识别研究[J].中草药,2023,54(9):2750-2757.
[6]陈雪婷,林诗铃,陈涛,等.UPLC-MS/MS法同时测定同仁牛黄清心丸中15个胆汁酸的含量[J].中国药房,2023,34(17):2074-2078.
[7]王倩倩,柴晓钰,王新宇,等.4种牛黄解毒制剂中胆汁酸类成分分析[J].中国药业,2025,34(2):49-55.
[8]国家药典委员会.中华人民共和国药典:一部[S].北京:中国医药科技出版社,2020:693-696.
[9]李娟,张龙,刘继,等.黄芩黄酮的研究进展[J].畜牧与饲料科学,2018,39(5):71-73.
[10]杨献光,孙阁阁,丁翠红,等.黄芩苷的生物学功能及作用机理[J].中国细胞生物学学报,2021,43(4):850-855.
[11]申云富,范小青.汉黄芩苷的药理活性研究进展[J].上海中医药大学学报,2016,30(4):98-101.
[12]王甜甜,王爽,李玲.黄芩素对EAM模型小鼠心肌组织纤维化的影响[J].精准医学杂志,2024,39(2):95-100,107.
[13]赵源,刘红波,唐志书,等.大黄蒽醌类物质药理作用研究进展[J].陕西中医,2024,45(6):863-865.
[14]刘桂元,罗利亚,李晓,等.大黄蒽醌类化合物抗炎作用研究进展[J].中成药,2023,45(11):3693-3701.
[15]马美玲,李晓,陈玉洁,等.基于多指标定量、多元统计分析模型的人参固本丸质量差异评价[J].现代中药研究与实践,2024,38(6):47-53.
[16]顾丽玲,姚曦,安容苗,等.竹叶提取物中7种黄酮成分含量测定及抗氧化分析[J].色谱,2024,42(10):972-978.
[17]潘丽丽,郝变,袁少雄,等.牛黄解毒片薄层鉴别和HPLC指纹图谱定性研究[J].中药材,2014,37(11):2087-2091.
[18]冯亚茹,周荣荣,耿佳乐,等.一测多评法同时测定大黄药材中8个结合型蒽醌含量的系统研究[J].药物分析杂志,2022,42(11):1884-1894.?收稿日期:2024-11-29
基本信息:
DOI:10.13728/j.1673-6427.2025.04.007
中图分类号:O657.72;R286.0
引用信息:
[1]王倩倩,柴晓钰,郝春晖等.高效液相色谱法同时测定牛黄解毒制剂中9个成分的含量[J].现代中药研究与实践,2025,39(04):44-48.DOI:10.13728/j.1673-6427.2025.04.007.
基金信息:
中国中医科学院创新基金项目(CI2021A00511)